The Identification of Medicinal Products (IDMP) is a set of standards defined by the International Organization for Standardization (ISO). The initiative has enjoyed cross-border support, with the regulatory authorities of the US, Canada, and Switzerland all publicly committing to adoption at some point in the future, with Japan, Australia, Russia, and Iran all expressing at least some level of interest. Europe is the first major region to officially adopt IDMP. Katrin Spaepen, Director of Strategy, Vault Submissions of Veeva Systems, explains that the European Medicines Agency (EMA) has mandated that all life sciences organisations in Europe and selling products in Europe demonstrate compliance by July 1, 2016, and has created a task force to regulate the standards.